Vjhemonc Podcast
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 72:51:50
- More information
Informações:
Synopsis
The video journal of hematological oncology
Episodes
-
Unmet needs in AL amyloidosis, novel treatment strategies being explored, and the role of CHIP
24/11/2023 Duration: 12minIn recent years, there have been promising therapeutic advances in light chain (AL) amyloidosis, however, several unmet needs remain in... The post Unmet needs in AL amyloidosis, novel treatment strategies being explored, and the role of CHIP appeared first on VJHemOnc.
-
iwNHL 2023 Session III: Recent updates with the use of antibody-drug conjugates in NHL
17/11/2023 Duration: 16minThe 20th International Workshop on Non-Hodgkin Lymphoma (iwNHL 2023) took place in Miami, FL, and brought together leading experts as... The post iwNHL 2023 Session III: Recent updates with the use of antibody-drug conjugates in NHL appeared first on VJHemOnc.
-
MPN diagnosis & treatment: novel agents in PV, clinical guidance for the use of JAK inhibitors & the growing role of combination approaches
10/11/2023 Duration: 12minThe treatment and management of myeloproliferative neoplasms (MPNs) including myelofibrosis (MF) and polycythemia vera (PV) has transformed in recent years,... The post MPN diagnosis & treatment: novel agents in PV, clinical guidance for the use of JAK inhibitors & the growing role of combination approaches appeared first on VJHemOnc.
-
iwNHL 2023 Session II: The evolving treatment landscape in mantle cell lymphoma
03/11/2023 Duration: 14minThe 20th International Workshop on Non-Hodgkin Lymphoma (iwNHL 2023) took place in Miami, FL, and brought together leading experts as... The post iwNHL 2023 Session II: The evolving treatment landscape in mantle cell lymphoma appeared first on VJHemOnc.
-
iwNHL 2023 Session I: Updates on the biology and treatment of T-cell lymphoma
27/10/2023 Duration: 13minThe 20th International Workshop on Non-Hodgkin Lymphoma (iwNHL 2023) took place in Miami, FL, and brought together leading experts as... The post iwNHL 2023 Session I: Updates on the biology and treatment of T-cell lymphoma appeared first on VJHemOnc.
-
iwAL 2023 Session IV: Transplantation and immunotherapies in AML: improving patient outcomes
20/10/2023 Duration: 14minThe 5th International Workshop on Acute Leukemias (iwAL 2023) took place in San Diego, CA, and brought together leading experts... The post iwAL 2023 Session IV: Transplantation and immunotherapies in AML: improving patient outcomes appeared first on VJHemOnc.
-
Classifying frailty and approaching elderly patients with lymphoma
13/10/2023 Duration: 11minWhile the treatment landscape of both Hodgkin and non-Hodgkin lymphoma (HL; NHL) has improved in recent years, there are several... The post Classifying frailty and approaching elderly patients with lymphoma appeared first on VJHemOnc.
-
Updates on the diagnosis, risk stratification and treatment of lower-risk MDS
06/10/2023 Duration: 19minThe treatment and management of lower-risk myelodysplastic syndromes (LR-MDS) has remained a challenge in the field, and several studies are... The post Updates on the diagnosis, risk stratification and treatment of lower-risk MDS appeared first on VJHemOnc.
-
iwAL 2023 Session III: The relevance of TP53 mutation in AML
29/09/2023 Duration: 09minThe 5th International Workshop on Acute Leukemias (iwAL 2023) took place in San Diego, CA, and brought together leading experts... The post iwAL 2023 Session III: The relevance of TP53 mutation in AML appeared first on VJHemOnc.
-
iwAL 2023 Session II: Novel treatments in AML: FLT3 inhibitors, combinations, and more
22/09/2023 Duration: 28minThe 5th International Workshop on Acute Leukemias (iwAL 2023) took place in San Diego, CA, and brought together leading experts... The post iwAL 2023 Session II: Novel treatments in AML: FLT3 inhibitors, combinations, and more appeared first on VJHemOnc.
-
iwAL 2023 Session I: Clonal hematopoiesis in AML, early detection and potential therapeutics
15/09/2023 Duration: 18minThe 5th International Workshop on Acute Leukemias (iwAL 2023) took place in San Diego, CA, and brought together leading experts... The post iwAL 2023 Session I: Clonal hematopoiesis in AML, early detection and potential therapeutics appeared first on VJHemOnc.
-
Applications of MRD in multiple myeloma: using MRD to guide treatment decisions
08/09/2023 Duration: 10minMeasurable residual disease (MRD) has become a key biomarker in the field of multiple myeloma (MM), and the sensitivity of... The post Applications of MRD in multiple myeloma: using MRD to guide treatment decisions appeared first on VJHemOnc.
-
Exploring and comparing the curative potential of CAR-T therapy & bispecific antibodies in R/R DLBCL
23/08/2023 Duration: 09minThe treatment and management of relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) remains a major unmet need, and in recent... The post Exploring and comparing the curative potential of CAR-T therapy & bispecific antibodies in R/R DLBCL appeared first on VJHemOnc.
-
Pre-MDS states: improving prognosis, novel therapeutic approaches, and challenges with distinguishing these conditions
16/08/2023 Duration: 10minMyelodysplastic syndromes (MDS) represent a heterogeneic group of disorders which remain a challenge to diagnose and treat. In recent years,... The post Pre-MDS states: improving prognosis, novel therapeutic approaches, and challenges with distinguishing these conditions appeared first on VJHemOnc.
-
Accelerated-phase MPNs: mutational landscape, challenges, and novel treatment strategies being explored
10/08/2023 Duration: 08minPatients with BCR-ABL negative myeloproliferative neoplasms (MPNs) are at risk of progressing to accelerated-phase or blast-phase disease (MPN-AP/BP). Several mutations, including... The post Accelerated-phase MPNs: mutational landscape, challenges, and novel treatment strategies being explored appeared first on VJHemOnc.
-
Determining the optimal sequencing of bispecifics and CAR-T cells in multiple myeloma
03/08/2023 Duration: 07minBispecific antibodies and CAR-T cells have transformed the myeloma treatment landscape in recent years, providing hope for patients with relapsed/refractory... The post Determining the optimal sequencing of bispecifics and CAR-T cells in multiple myeloma appeared first on VJHemOnc.
-
Overcoming barriers to CAR-T therapy: improving access and cost
27/07/2023 Duration: 11minCAR-T therapy has become a promising novel option for patients with relapsed/refractory (R/R) hematological malignancies, providing hope to several individuals... The post Overcoming barriers to CAR-T therapy: improving access and cost appeared first on VJHemOnc.
-
The importance of addressing quality of life and improving symptom management in MPNs
19/07/2023 Duration: 06minMyeloproliferative neoplasms (MPNs) represent a challenging group of diseases to treat, and patients with MPNs suffer from several symptoms which... The post The importance of addressing quality of life and improving symptom management in MPNs appeared first on VJHemOnc.
-
Updates in the treatment and management of amyloidosis and the importance of the multidisciplinary team
11/07/2023 Duration: 08minAmyloidosis is a rare disease in which insoluble amyloid proteins are deposited in tissues or organs, resulting in organ damage.... The post Updates in the treatment and management of amyloidosis and the importance of the multidisciplinary team appeared first on VJHemOnc.
-
Hemophilia: the current standard of care and the value of novel gene therapies
05/07/2023 Duration: 06minOver the years, the hemophilia treatment landscape has transformed, with novel agents aiming to improve patient care and quality of... The post Hemophilia: the current standard of care and the value of novel gene therapies appeared first on VJHemOnc.